Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guerin

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 113-119

  Kemp, E B ^a   Belshe, R B ^a   Hoft, D F ^a,b  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; BCG VACCINE; GAMMA INTERFERON; TUBERCULIN;

ADULT; ARTICLE; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INTERFERON PRODUCTION; INTRADERMAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST;

EID: 0030017411     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.113     Document Type: Article

References (29)

1. Starke JR, Connelly KK. Bacille Calmette-Guérin vaccine. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. 2nd ed. Philadelphia: WB Saunders, 1994:439-73.
2. Mande R, Fillastre C, Rouillon A. Vaccination. In: BCG Vaccination. London: Dawsons of Pall Mall, 1968:57-82.
3. Rosenthal SR. Routes and methods of administration. In: BCG vaccine: tuberculosis-cancer. Littleton, MA: PSG Publishing, 1980:146-75.
4. Gheorghiu M. The present and future role of BCG vaccine in tuberculosis control. Biologicals 1990;18:135-41.
5. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
6. Landi S, Ashley MJ, Grzybowski S. Tuberculin sensitivity following the intradermal and multiple puncture methods of BCG vaccination. Can Med Assoc J 1967;97:222-5.
7. Rahaju N, Rahaju NN, Widya M, Madijono B, Sutedjo. Direct BCG immunization by intracutancous route and multiple-puncture method. Paediatr Indonesia 1970;10:89-97.
8. Smith DW. Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res 1985;22:1-97.
9. Jespersen A. Studies on tuberculin sensitivity and immunity in guinea-pigs induced by vaccination with varying doses of BCG vaccine. Acta Pathol Microbiol Scand 1956;38:203-9.
10. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-2.
11. Workshop report: summary, conclusions, and recommendations from the international workshop on "research towards global control and prevention of tuberculosis: with an emphasis on vaccine development." J Infect Dis 1988;158:248-53.
12. Fine PEM. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 1989;11(suppl 2):S353-9.
13. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988;140:3589-93.
14. Flesch I, Kaufmann SHE. Mycobacterial growth inhibition by interferon-activated bone marrow macrophages and differential susceptibility amongst strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-13.
15. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
16. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
17. + T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 1989;112:161-82.
18. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481-97.
19. Rook GAW, Champion BR, Steele J, Varey AM, Stanford JL. I-A restricted activation by T cell lines of anti-tuberculous activity in murine macrophages. Clin Exp Immunol 1985;159:414-20.
20. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25.
21. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993;61:197-203.
22. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 1991;59:665-70.
23. Andersen P, Askgaard D, Ljungqvist L, Weis Bentzon M, Heron I. T-cell prolifefative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991;59:1558-63.
24. Orme IM, Miller ES, Roberts AD, et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992;148:189-96.
25. Andersen P, Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993;61:844-51.
26. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994;62:2536-44.
27. Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992;60:4781-92.
28. Horwitz MA, Lee BE, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995;92:1530-4.
29. Brewer MA, Edwards KM, Palmer PS, Hinson HP. Bacille Calmette-Guérin immunization in normal healthy adults. J Infect Dis 1994;170:476-9.